Break of Structure for Bullish | At least 12% profitableWeekly Chart
Dynavax Technologies Coroporation ( NASDAQ:DVAX ) has broken up descending trend line and trading at $14.35 now
- Return on Equity over 72% on 2022 and over 55% on Quarter I/2023
When DVAX retest the support to confirm breakout and if it's true that a good chance to buy for mid-term
Wait for next move
DVAX trade ideas
Dynavax Technologies dropping. DVAXFlat formation with C wave underway. Some fib levels are shown, as with most flats the expectation is the C wave will end more or less around A/B pivot.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely levels that the market will go to. Having said that, the market will always do what it wants and always has a mind of its own. Therefore, none of this is financial advice, so do your own research and rely only on your own analysis. Trading is a true one man sport. Good luck out there and stay safe!
WATCHING $DVAX for entry at 11.50 Analysis & Key LevelsWATCHING $DVAX for entry at 11.50 Analysis & Key Levels
Red = Resistance
Green = Support
Blue = trend lines
180 EMA = Purple
I am not your financial advisor. Anything can happen… I’m just posting what I see… but the risk is on you if you decide to trade the setup with me.
I certainly don’t win them all so be mindful of your position sizes and do your due diligence. I’m happy to answer questions to the best of my ability.
Can Covid Vax Spark DVAX?DVAX retracement plotted using recent lows and the high from Aug 2018...figured that would be more than enough on the big picture to see any potential levels of interest. In this case, sure enough, there were. Mainly, the 236 fib line has been an area of higher traffic over the last 3 years. Further, DVAX has yet to establish a substantial support above this level for an extended period of time. Thanks to the Delta variant, COVID vax is in focus. For DVAX however, there are possibly a few other things to keep in mind that could be important to keep in mind right now:
" Conveniently for those just beginning to look at DVAX stock right now, the company gave an overview of its platforms earlier this month in a second-quarter earnings update. Its HEPLISAV-B and CpG 1018 platforms generated revenue for the quarter, with $39 million coming from CpG 1018 and $13.7 million from HEPLISAV-B. In particular, the HEPLISAV-B revenues were the highest quarterly figures for the treatment to date. Dynavax has gone further and entered into a commercialization agreement with Bavarian Nordic for the German market...With the coronavirus continuing to stoke uncertainty, vaccine stocks remain in focus. Dynavax’s CpG 1018 adjuvant has acted as a recent catalyst. The adjuvant is designed to increase vaccine immune response when used in vaccines, including its own HEPLISAV-B. Now, with coronavirus vaccines showing benefits, the uptick in cases has helped build more interest in the company’s pipeline...In fact, Dynavax has entered into commercial supply agreements with numerous companies, including Biological E and Clover Biopharmaceuticals, to use Dynavax’s adjuvant in the commercial production of each company’s respective coronavirus vaccine candidates. "
Quote Source + Read more: Hot Biotech Stocks That Deserve Your Attention In August 2021
DVAX Long term I am bullish on DVAX. But the market is already topped up and it is crying out for a correction to 6.8 area.
There are fundamentals (quite a few in the pipeline) that support the bullish idea but before any bullishness, it needs correction. I have closed my long positions at 10.7 (from 4.5) and waiting for a good entry point.
if you liked this idea or if you have your own opinion about it, write in the comments.
Plan your trade and trade the plan
Short squeeze mini series #16What Is a Short Squeeze?
A short squeeze occurs when a stock or other
asset jumps sharply higher, forcing traders who
had bet that its price would fall, to buy it in
order to forestall even greater losses. Their
scramble to buy only adds to the upward
pressure on the stock's price
KEY TAKEAWAYS
*A short squeeze accelerates a stock's price rise
as short-sellers bail out to cut their losses.
*Contrarian investors try to anticipate a short
squeeze and buy stocks that demonstrate a
strong short interest.
*Both short-sellers and contrarians are making
risky moves. A wise investor has additional
reasons for shorting or buying that stock.